Clinical Trials Browser

Phase NA × OTHER_GOV × HER2-positive Breast Cancer × Clear all

NCT07198672 2025-09-30

Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag

Phase NA Not yet recruiting

HER2-positive Breast Cancer